Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Bunte, Tommy
LIGHTHOUSE II, NCT05193994: Triumeq in Amyotrophic Lateral Sclerosis	Active, not recruiting	3	390	Europe, RoW	Dolutegravir, Abacavir and Lamivudine, Triumeq, Placebo	Macquarie University, Australia, King's College London, Stichting TRICALS Foundation	Amyotrophic Lateral Sclerosis	08/26	08/26